Sartorius Stedim Biotech (Sartorius Stedim Biotech) Total Stockholders Equity : $2,877 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Total Stockholders Equity?

Sartorius Stedim Biotech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,877 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sartorius Stedim Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was $31.21. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sartorius Stedim Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 was 1.40.

Sartorius Stedim Biotech Total Stockholders Equity Historical Data

The historical data trend for Sartorius Stedim Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Total Stockholders Equity Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,287.47

1,749.54

1,871.07

2,594.60

2,876.66

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															2,594.60	2,591.33	2,783.53	2,769.05	2,876.66

Sartorius Stedim Biotech (OTCPK:SDMHF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sartorius Stedim Biotech's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2876.663	-	0)	/	92.165
	=	31.21

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sartorius Stedim Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(86.26	+	3929.008)	/	2876.663
	=	1.40

Sartorius Stedim Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.